GENEVA, Feb. 2 -- PROQR THERAPEUTICS II B.V. (Zernikedreef 92333 CK Leiden) filed a patent application (PCT/EP2025/070967) for "ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF METABOLIC DISORDERS" on Jul 22, 2025. With publication no. WO/2026/022136, the details related to the patent application was published on Jan 29, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): KLEIN, Bart (ProQR Therapeutics II B.V.Zernikedreef 92333 CK Leiden), HOLKERS, Maarten (ProQR Therapeutics II B.VZernikedreef 92333 CK Leiden), POTMAN, Marko (ProQR Therapeutics II B.V.Zernikedreef 92333 CK Leiden)
Abstract: Th...